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Identification of Novel Protein Targets for Modification by
15-Deoxy-12,14-Prostaglandin J2 in Mesangial Cells Reveals
Multiple Interactions with the Cytoskeleton
Konstantinos Stamatakis, Francisco J. Sa´nchez-Go´mez, and Dolores Pe´rez-Sala
Departamento de Estructura y Funcio´n de Proteı´nas, Centro de Investigaciones Biolo´gicas, Madrid, Spain
The cyclopentenone prostaglandin 15-deoxy-12,14-PGJ2 (15d-PGJ2) has been shown to display protective effects against renal
injury or inflammation. In cultured mesangial cells (MC), 15d-PGJ2 inhibits the expression of proinflammatory genes and
modulates cell proliferation. Therefore, cyclopentenone prostaglandins (cyPG) have been envisaged as a promise in the
treatment of renal disease. The effects of 15d-PGJ2 may be dependent on or independent from its role as a peroxisome
proliferator–activated receptor agonist. It was shown recently that an important determinant for the peroxisome proliferator–
activated receptor–independent effects of 15d-PGJ2 is the capacity to modify proteins covalently and alter their function.
However, a limited number of protein targets have been identified to date. Herein is shown that a biotinylated derivative of
15d-PGJ2 recapitulates the effects of 15d-PGJ2 on the stress response and inhibition of inducible nitric oxide synthase levels
and forms stable adducts with proteins in intact MC. Biotinylated 15d-PGJ2 was then used to identify proteins that potentially
are involved in cyPG biologic effects. Extracts from biotinylated 15d-PGJ2–treated MC were separated by two-dimensional
electrophoresis, and the spots of interest were analyzed by mass spectrometry. Identified targets include proteins that are
regulated by oxidative stress, such as heat-shock protein 90 and nucleoside diphosphate kinase, as well as proteins that are
involved in cytoskeletal organization, such as actin, tubulin, vimentin, and tropomyosin. Biotinylated 15d-PGJ2 binding to
several targets was confirmed by avidin pull-down. Consistent with these findings, 15d-PGJ2 induced early reorganization of
vimentin and tubulin in MC. The cyclopentenone moiety and the presence of cysteine were important for vimentin
rearrangement. These studies may contribute to the understanding of the mechanism of action and therapeutic potential of
cyPG.
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P rostaglandins with cyclopentenone structure are en-dogenous eicosanoids that are generated by nonenzy-matic dehydration of arachidonic acid metabolites. Cy-
clopentenone prostaglandins (cyPG) exert varied biologic
actions, including inhibition of cell proliferation in several can-
cer cell lines and anti-inflammatory and antiviral activities. The
molecular basis for these varied effects is multiple. The com-
mon feature of these prostaglandins is the presence of an un-
saturated carbonyl group in the cyclopentane ring (cyclopen-
tenone; see Figure 1). This structure was found early to be an
important requirement for the antitumoral and antiviral effects
of cyPG (1). This moiety confers cyPG the capacity to form
covalent adducts with thiol groups in glutathione or in proteins
by Michael addition (Figure 1). Modification of critical cysteine
residues in signaling proteins can modulate cell function. More-
over, some cyPG, such as 15-deoxy-12,14-PGJ2 (15d-PGJ2), may
act as ligands for the transcription factors of the nuclear recep-
tor superfamily known as peroxisome proliferator–activated
receptors (PPAR), which have been reported to play important
roles in the regulation of lipid metabolism (2) and in cardio-
vascular and renal pathophysiology (3,4). For these reasons, the
potential use of cyPG as therapeutic agents has been explored
in numerous studies using cellular and animal models of in-
flammation or injury. Protective effects of micromolar concen-
trations of 15d-PGJ2 against ischemia-reperfusion injury and
multiple-organ failure caused by endotoxic shock have been
reported (5–7). These beneficial effects were associated with an
inhibition of the inflammatory response and of the activation of
transcription factors NF-B and activator protein 1 (AP-1). An-
ti-inflammatory effects of 15d-PGJ2 have also been evidenced in
cultured cells. In mesangial cells (MC), 15d-PGJ2 inhibited cy-
tokine-elicited induction of cyclo-oxygenase-2 (8) and mono-
cyte chemoattractant protein-1 (9). By using an analog of 15d-
PGJ2 that retains full PPAR agonist activity but lacks the
cyclopentenone structure, we showed recently that the capacity
of 15d-PGJ2 to modify covalently cellular thiols plays a key role
in the inhibition of proinflammatory genes such as inducible
nitric oxide (iNOS), cyclo-oxygenase-2, and ICAM-1 in MC (10).
Several proteins that are involved in the activation of NF-B
and AP-1, as well as components of the transcription factors
themselves, have been identified as targets for modification by
15d-PGJ2. Modification of IKK reduces NF-B activation
(11,12), whereas 15d-PGJ2 addition to critical cysteines in the
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DNA binding domains of NF-B and AP-1 proteins results in
inhibition of DNA binding (13,14). CyPG also modulate cell
proliferation. In MC, a biphasic effect of 15d-PGJ2 has been
reported, with low concentrations promoting cell proliferation
and higher concentrations inducing cell death (15). On this
basis, a potential for the use of cyPG in the restoration of
glomerular architecture in progressive glomerular disease has
been postulated (15). Another important feature of the effect of
15d-PGJ2 is the induction of a heat-shock response in many cell
types, including MC (16,17). This stress response, which re-
quires the cyclopentenone moiety, could contribute to the ben-
eficial effects of 15d-PGJ2 in renal cell injury during inflamma-
tion or ischemia (17). Therefore, the modification of protein
thiols by cyPG, which could be referred to as protein prosta-
nylation, seems to play an important role in 15d-PGJ2 protective
effects. Nevertheless, the potential for cytotoxic effects of 15d-
PGJ2 should also be considered. The identification of proteins
that are susceptible to be modified by cyPG addition could help
define novel targets for therapeutic intervention and identify
potential adverse effects. In a previous study, we observed the
presence of multiple targets for modification by biotinylated
15d-PGJ2 in MC (10). Here we address the identification of the
modified proteins by proteomic approaches (Figure 1) and
report the binding of biotinylated 15d-PGJ2 to several previ-
ously unknown targets. In addition, we provide evidence for
the potential involvement of protein prostanylation in the reg-
ulation of MC cytoskeletal organization.
Materials and Methods
Materials
15d-PGJ2 was from Calbiochem-Novabiochem (San Diego, CA) or
from Cayman Chemical (Ann Arbor, MI). 15d-PGJ2 biotinylated at the
carboxyl group was provided by Dr. F.J. Can˜ada (Centro de Investiga-
ciones Bilo´gicas, Madrid, Spain). Recombinant human IL-1 (5  107
U/mg) was from Roche Diagnostics S.L. (Barcelona, Spain). TNF- was
from Serotec (Oxford, UK). Polyclonal anti-iNOS (sc-651) and anti-
RhoGDI (sc-360) were from Santa Cruz Biotechnology (Santa Cruz,
CA). Horseradish peroxidase (HRP)-conjugated anti-rabbit Ig were
from Dako (Glostrup, Denmark). Anti-vimentin, HRP-conjugated
streptavidin, and enhanced chemiluminescence reagents were from
Amersham Biosciences (Barcelona, Spain). Anti–heat-shock protein 90
(anti-Hsp90) was from Stressgen (Victoria, BC, Canada). The monoclo-
nal anti-tubulin antibody was the gift of Dr. I. Barasoaı´n (Centro de
Investigaciones Biolo´gicas, Madrid, Spain). Secondary antibodies for
immunofluorescence anti-rabbit–Texas Red, anti-mouse–Alexa488, and
Phalloidin-Alexa546 were from Molecular Probes (Invitrogen Life
Technologies S.A., Barcelona, Spain). All other reagents were of the
highest purity available from Sigma Chemical Co. (St. Louis, MO).
Cell Culture
Cell culture media and supplements were from Invitrogen. Rat MC
were obtained as reported earlier (18). Cells were grown in RPMI 1640
supplemented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin,
and 100 g/ml streptomycin. Throughout this study, passages 7 to 18
were used. Cell treatments were performed in serum-free medium.
CyPG were added in DMSO. Final DMSO concentration was 0.1%
(vol/vol). Control cells received an equivalent amount of DMSO. For
cytokine stimulation, confluent MC were incubated in serum-free me-
dium for 24 h before the addition of a combination of 3 ng/ml IL-1
plus 37 ng/ml TNF-.
Incorporation of Biotinylated 15d-PGJ2 into MC Proteins
MC were incubated with biotinylated 15d-PGJ2 for 2 h in serum-free
medium. These conditions were found to yield maximal protein label-
ing. Lysates were obtained by disrupting cells in 50 mM Tris (pH 7.5);
0.1 mM EDTA; 0.1 mM EGTA; 0.1 mM -mercaptoethanol; 0.5% SDS
that contained 2 g/ml of each of the protease inhibitors leupeptin,
pepstatin A, and aprotinin; and 1.3 mM Pefablock (Roche). Biotin
incorporation was assessed by Western blot.
Protein Electrophoresis and Identification
For two-dimensional electrophoresis, cells were lysed in 20 mM
Hepes (pH 7.2), 50 mM NaCl, 1% NP-40, 0.3% sodium deoxycholate,
and 0.1% SDS plus protease inhibitors. Aliquots of cell lysates that
contained 600 g of protein were precipitated with 10% TCA, resus-
pended in 260 l of IEF sample buffer (4% CHAPS, 2 M thiourea, 7 M
urea, 100 mM dithiothreitol, and 0.5% Bio-lyte ampholytes), split in two
aliquots and loaded on ReadyStrip IPG Strips (pH 3 to 10; Bio-Rad,
Hercules, CA) for isoelectric focusing on a Protean IEF cell (Bio-Rad),
Figure 1. Strategy for the detection and identification of proteins
that were modified by biotinylated 15-deoxy-12,14-PGJ2 (15d-
PGJ2). Intact mesangial cells (MC) are incubated with the bio-
tinylated analog of 15d-PGJ2. This analog binds to cysteine
residues in certain proteins by Michael addition. Duplicate
samples from cell lysates that contained modified proteins are
analyzed in parallel by two-dimensional (2D) electrophoresis
followed by Western blot or total protein staining. Biotin-pos-
itive spots are analyzed by mass spectrometry techniques.
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following the instructions of the manufacturer. For the second dimen-
sion, strips were loaded on duplicate 15% polyacrylamide SDS gels.
Gels were stained with GelCode Blue (Pierce, Rockford, IL). One of the
gels was subsequently transferred to Immobilon P membrane (Milli-
pore, Bedford, MA) and used for localization of biotinylated 15d-PGJ2–
labeled spots by Western blot (10). The Coomassie-stained spots that
co-migrated with the biotin-positive proteins were excised from the
duplicate gel. The accuracy of the procedure was confirmed by the
disappearance of the biotin signal in the Western blot of the gel used for
picking. The confirmed spots were subjected to in-gel digestion with
trypsin (19) and analysis by matrix-assisted laser desorption ioniza-
tion–time of flight mass spectrometry (MALDI-TOF MS) using
-cyano-4-hydroxy-cinnamic acid as the matrix. Mass spectra were
calibrated internally using the peptide mix resulting from trypsin au-
tolysis. Proteins were identified with the MASCOT (Matrix Science,
London, UK) searching algorithms using the monoisotopic peptide
masses and a peptide mass tolerance of 50 ppm. When indicated,
protein identity was confirmed by MALDI-TOF MS-MS analysis of
selected peptides using the MALDI-tandem TOF mass spectrometer
4700 Proteomics Analyzer (Applied Biosystems, Framingham, MA).
Avidin Pull-Down Assays
MC were incubated in the presence of 5 M 15d-PGJ2 or biotinylated
15d-PGJ2. Cells were lysed, and biotinylated proteins were purified by
adsorption onto Neutravidin beads (Pierce) following the manufactur-
er’s instructions. Proteins of interest were detected in the eluate by
Western blot.
Fluorescence Microscopy
Cells that were grown on glass coverslips were treated with various
agents for 2 h. For immunofluorescence, cells were fixed with 3.5%
formaldehyde and permeabilized with 0.1% Triton X-100. After block-
ing with 1% BSA, they were incubated with primary antibodies at 1:200
dilution. Subsequently, coverslips were washed with PBS and incu-
bated with secondary antibodies at 1:200 dilution and/or with DAPI for
1 h. Coverslips were mounted with Fluorsafe (Calbiochem) and images
were obtained with a Leica TCS-SP2-AOBS-UV confocal inverted mi-
croscope, using a 63/1.4 objective.
Plasmids and Transfections
Full-length human cDNA vimentin (Origene, Rockville, MD) was
cloned into the EcoRI, SmaI sites of the pEGFP-C1 vector (Clontech,
Palo Alto, CA) to obtain GFP-vimentin-wt. Cysteine 328 was mutated
to serine using the Quickchange XL site-directed mutagenesis kit from
Stratagene (La Jolla, CA) and primers forward 5-GGTGCAGTCCCT-
CACCTCTGAAGTGGATGCCC-3 and reverse 5-GGGCATCCACT-
TCAGAGGTGAGGGACTGCACC-3 to obtain GFP-vimentin-C328S.
Cells that were grown on glass coverslips were transfected with con-
structs that were purified with Endofree plasmid kit (Qiagen, Valencia,
CA) using Lipofectamine 2000 (Invitrogen). After 24 h, cells were
treated as described above.
Results
Effects of Biotinylated 15d-PGJ2 on the Stress and
Inflammatory Responses of MC
The protective effects of cyPG have been attributed to their
ability to induce a cell stress response and attenuate the inflam-
Figure 2. Effects of biotinylated 15d-PGJ2 in MC. (A) MC were
incubated in the presence of the indicated concentrations of
cyclopentenone prostaglandins (cyPG) or vehicle for 16 h and
the levels of constitutive and inducible heat-shock protein 70
(HSC70/Hsp70) were assessed by Western blot. (B) The induc-
tion of inducible nitric oxide synthase (iNOS) was elicited by
treatment of MC with a cytokine mixture (Ck) for 16 h. CyPG
were added to the medium 2 h before the addition of cytokines.
Levels of iNOS were detected by Western blot. The levels of
actin were used as a control for intersample variability. Results
shown are representative of three experiments with similar
results.
Figure 3. Labeling of MC proteins with biotinylated 15d-PGJ2.
(A) MC were incubated with biotinylated 15d-PGJ2 as above,
and the incorporation of the biotin label into MC proteins was
assessed by Western blot and detection with horseradish per-
oxidase (HRP)-conjugated streptavidin using enhanced chemi-
luminescence. (B) Lysates from control or biotinylated 15d-
PGJ2–treated cells were incubated in the presence of 10 mM
dithiothreitol or 0.1 N NaOH for 30 min at room temperature.
After desalting by gel filtration, lysates were analyzed by SDS-
PAGE and Western blot, as above. To ensure even protein
loading, membranes were stripped and rehybridized with anti-
actin antibody. Results shown are representative of three
assays.
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matory response. Covalent protein modification is important
for these effects (10,20). To substantiate the use of biotinylated
15d-PGJ2 as a tool to identify potential targets for cyPG action,
we assessed its ability to mimic the effects of 15d-PGJ2. The
induction of Hsp70 is a hallmark of the heat-shock response.
Therefore, we assessed Hsp70 protein levels in cyPG-treated
MC. As previously reported (17), micromolar concentrations of
15d-PGJ2 potently elicited Hsp70 expression. This effect was
mimicked by the biotinylated analog (Figure 2A). We have
previously shown that micromolar concentrations of 15d-PGJ2
abolish cytokine-elicited iNOS induction in MC (10). Treatment
of MC with biotinylated 15d-PGJ2 also provoked a marked
inhibition of iNOS levels (95% reduction with 5 M and unde-
tectable levels with 10 M biotinylated 15d-PGJ2, respectively;
Figure 2B). These observations show that the biotinylated ana-
log recapitulates the anti-inflammatory and stress-inducing ef-
fects of 15d-PGJ2 in MC.
Binding of Biotinylated 15d-PGJ2 to Cellular Proteins in
Intact MC
The effects of biotinylated 15d-PGJ2 on MC responses were
associated with the modification of cellular proteins (Figure
3A). Binding of cyPG to cellular proteins occurs through the
formation of adducts with free cysteine residues by Michael
addition (Figure 1). Using radioactively labeled cyPG, this
binding has been shown to be stable under reducing conditions;
however, it can be hydrolyzed by alkali (21). As shown in
Figure 3B, binding of biotinylated 15d-PGJ2 to proteins in MC
lysates was resistant to treatment with 10 mM dithiothreitol,
but it was clearly reduced after treatment with 0.1 N NaOH,
thus showing the same susceptibility as the binding of non-
modified cyPG. Taken together, these results support the use of
biotinylated 15d-PGJ2 as a tool to identify protein targets for
Figure 4. Analysis of biotinylated 15d-PGJ2–modified proteins
by 2D electrophoresis. Cell lysates from MC incubated with
5 M biotinylated 15d-PGJ2 for 2 h were analyzed by 2D
electrophoresis as described in Materials and Methods. (Up-
per panel) Total protein staining with colloidal Coomassie
blue. (Lower panel) Western blot and detection of modified
proteins by incubation with HRP-streptavidin. Spots that
were excised are indicated by numbers in the upper panel
and the position of the co-migrating spots in the lower panel
is indicated by arrowheads. A similar pattern of biotin stain-
ing was obtained in five independent experiments.
Figure 5. Matrix-assisted laser desorption ionization–time of
flight mass spectrometry (MALDI-TOF MS) analysis of spot 3.
Spot 3 from Figure 4 was digested in gel with trypsin, and the
resulting peptides were analyzed by MALDI-TOF MS as de-
tailed in the experimental section. (A) Typical mass spectrum
from a representative experiment. (B) List of the monoisotopic
masses of some of the peptides identified showing their posi-
tion in the vimentin sequence (MSO, compatible with oxidation
of methionine residues).
92 Journal of the American Society of Nephrology J Am Soc Nephrol 17: 89–98, 2006
covalent modification potentially involved in the biologic ef-
fects of cyPG.
Identification of Biotinylated 15d-PGJ2–Modified MC
Proteins
To identify the proteins that are modified by 15d-PGJ2 in MC,
we analyzed lysates from biotinylated 15d-PGJ2–treated cells
by two-dimensional electrophoresis. The patterns that were
given by Coomassie staining and detection of biotin with HRP-
streptavidin are shown in Figure 4. After superimposition of
both patterns, the Coomassie-stained proteins that coincided
with the biotin-positive spots were excised and analyzed by
tryptic digestion and MALDI-TOF MS. Figure 5 shows a rep-
resentative MALDI-TOF mass spectrum and peptide mass fin-
gerprinting analysis that corresponds to spot 3 from Figure 4,
identified as vimentin. Table 1 displays a list of the proteins
identified along with a summary of the identification data. As
control for the selectivity of cyPG addition, we analyzed several
spots that were clearly detected with Coomassie but gave no
signal with HRP-streptavidin. However, several biotin-positive
spots were detected by Western blot and could not be matched
to any of the Coomassie-stained spots and may represent less
abundant proteins that get modified in a high proportion.
The binding of biotinylated 15d-PGJ2 to some of the proteins
identified was confirmed by pull-down assays using Neutravi-
din-agarose. Figure 6 shows that Hsp90, vimentin, tubulin, and
actin, present in lysates from MC that were treated with bio-
tinylated 15d-PGJ2, were selectively retained on avidin beads.
In contrast, the abundant cytosolic protein RhoGDI was not
detected in the avidin-binding fraction, thus suggesting that
this protein is not a target for modification by cyPG. The
various proteins that were found in the avidin-binding fraction
were present in different proportions with respect to their
levels in total lysates. Vimentin and tubulin were the proteins
retained in a higher proportion, whereas only a minor fraction
of total Hsp90 was retained on avidin beads. This may reflect
the different degree of modification of these targets by biotin-
ylated 15d-PGJ2.
Interactions of 15d-PGJ2 with Cytoskeletal Proteins in MC
Several of the biotinylated 15d-PGJ2–modified proteins iden-
tified are constituents of microfilaments, microtubules, or in-
termediate filaments and are involved in cell architecture and
dynamics. Therefore, we explored the effect of 15d-PGJ2 on MC
cytoskeletal organization by immunofluorescence (Figure 7).
Incubation of MC with 15d-PGJ2 induced marked morphologic
changes in the vimentin filament network. Control MC showed
a typical vimentin pattern characterized by abundant fine fila-
ments extending from the nuclear periphery toward the plasma
membrane (Figure 7A). The position and the integrity of cell
nuclei were shown by DAPI staining. Treatment with 15d-PGJ2
resulted in the disappearance of vimentin filaments from the
cell periphery and accumulation in the perinuclear region. For
better evidencing this effect, cells were stained with an anti-
body against the cytosolic protein RhoGDI. This clearly showed
the loss of vimentin staining from extensive areas of the cyto-
plasm. The organization of tubulin also showed early changes
after treatment with 15d-PGJ2, consisting of a reduction in the
density and the length of microtubules, compatible with a
disruption of the tubulin network. In contrast, actin fibers were
not appreciably affected by 15d-PGJ2 treatment under these
conditions. The reorganization of vimentin and tubulin net-
works was not accompanied by changes in the levels of these
proteins as assessed by Western blot (Figure 7B). It is interest-
ing that 9,10-dihydro-15d-PGJ2, an analog of 15d-PGJ2 that
Table 1. Proteins identified by trypsin digestion and mass spectrometrya














1 Hsp90  P34058 83475 5.06 9 9 —
2 Pyruvate kinase M2  A26186 58183 7.40 15 27 1462.9
3 Vimentin  P31000 53626 5.06 51 78 —
4 Tubulin  A25113 50361 4.79 36 62 —
5 Actin  NP112406 41736 5.26 12 38 —
6 Methylthioadenosine
phosphorylase
 BAB23788 31612 6.71 11 44 —
7 Tropomyosin  S34124 29245 4.75 8 34 —
8 IgE-dependent histamine
releasing factor
 S00775 19564 4.76 7 26 1213.6
9 Nucleoside diphosphate
kinase
 A38369 17386 6.92 8 63 1175.6
aSpots that were excised from the gel shown in Figure 4 were identified by tryptic digestion and matrix assisted laser
desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Shown are the spot number, name of the identified
protein, whether it showed positive biotin staining, the accession number for the protein in the NCBI database, the theoretical
molecular mass and isoelectric point, the number of peptides matched according to the Mascot database, the percentage of the
protein sequence that is covered by the identified peptides, and the mass of some peptides, the sequence of which was
confirmed by MALDI-TOF-TOF MS (msms) analysis.
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lacks the cyclopentenone moiety and displays reduced ability
to bind to proteins (10), did not induce vimentin or tubulin
redistribution, thus suggesting that thiol modification is impor-
tant for the effects of 15d-PGJ2 on MC cytoskeletal organization.
Consistent with this, biotinylated 15d-PGJ2 induced a marked
redistribution of intermediate vimentin filaments and microtu-
bules that resembled the effects of nonmodified 15d-PGJ2 (Fig-
ure 7C).
To confirm the importance of cysteine modification in the
effects of cyPG, GFP-vimentin-wt and C328S mutant constructs
were transfected in MC. GFP-vimentin was incorporated into
the endogenous intermediate filament network, as it has been
characterized previously (22). Cells that were transfected with
GFP-vimentin-wt showed marked vimentin collapse in re-
sponse to 15d-PGJ2 treatment (Figure 8). It is interesting that the
proportion of cells that underwent vimentin reorganization
was significantly lower in cells that were transfected with the
GFP-vimentin-C328S mutant. These results indicate that muta-
tion of this cysteine residue partially protects the vimentin
network against 15d-PGJ2–elicited disruption.
Discussion
CyPG have been reported to exert anti-inflammatory, anti-
proliferative, and antiviral effects in several experimental sys-
tems. The ability of these compounds to covalently modify
cellular proteins is an important mechanism for these effects.
Biotinylated analogs of cyPG have been used as probes to
explore these interactions. Here we have shown that biotinyl-
ated 15d-PGJ2 mimics the effects of 15d-PGJ2 on the heat-shock
and inflammatory responses of MC in culture and forms stable
adducts with proteins that display resistance to treatment with
reducing agents but are disrupted under alkaline conditions, as
expected of Michael adducts between proteins and cyPG.
CyPG can bind to a broad but defined set of cellular proteins.
Work from several laboratories, including ours, has led to the
identification of several targets for prostanylation. Among
these targets are the transcription factors NF-B and AP-1
(12–14); IKK (11,23); proteins involved in cellular redox status
regulation, such as thioredoxin and thioredoxin reductase
(24,25); the protein Keap-1, a sensor of electrophilic stress and
regulator of the transcription factor Nrf-2 (26,27); and H-Ras
proteins (28). In this work, we used a proteomic approach to
identify protein targets for cyPG addition. Using biotinylated
15d-PGJ2, we detected at least 50 biotin-positive spots in ex-
tracts from MC. The total number of potential targets for cyPG
action may be higher because some minor proteins may not be
detected by this assay. Also, the biotin moiety may preclude
access of the biotinylated cyPG to cysteine residues in some
proteins or interactions for which the presence of the carboxyl
group of the cyPG is important, as it has been proposed for
PPAR- (29). In this study, we identified several important
regulatory proteins. Hsp90 regulates proteins that are impli-
cated in apoptotic, survival, and growth pathways (30). Hsp90
has been shown to undergo reversible cysteine-targeted oxida-
tion during renal oxidative stress (31). Several reactive cysteine
residues at Hsp90 C-terminus seem to be important for function
(32,33). Therefore, it would be interesting to explore the impli-
cations of cyPG addition to Hsp90 for chaperone function or
heat-shock response.
Other proteins detected include nucleoside diphosphate ki-
nase, a multifunctional enzyme involved in the maintenance of
the cellular pools of nucleoside triphosphate and in transcrip-
tional regulation (34). Nucleoside diphosphate kinase has been
shown to undergo S-thiolation or disulfide cross-linking under
conditions of oxidative stress, which could have implications in
function switching (34–36). The enzyme methylthioadenosine
phosphorylase is involved in the synthesis of methionine and in
the regulation of polyamine synthesis (37). On the basis of
previous evidence, modification of methylthioadenosine phos-
phorylase by cyPG could have implications for cell prolifera-
tion or apoptosis (38).
The major targets of biotinylated 15d-PGJ2 in MC seem to be
vimentin, tubulin, and actin. These results shed light on the
cellular fate of cyPG by showing that an important proportion
of the cellular PG-protein adducts is constituted by cytoskeletal
Figure 6. Retention of biotinylated 15d-PGJ2–modified proteins
on avidin beads. Cell lysates from MC incubated with 5 M
15d-PGJ2 or biotinylated 15d-PGJ2 for 2 h were subjected to
pull-down assays with neutravidin agarose beads. The levels of
the proteins of interest in total cell lysates and in the avidin-
binding fractions were assessed by Western blot. Results shown
are representative of at least three assays for every protein.
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proteins. In addition, we found the contractile protein tropo-
myosin. The results presented here show extensive reorganiza-
tion of the intermediate filament network, consisting in a pe-
rinuclear collapse of vimentin filaments. It is interesting that a
similar collapse of the vimentin network has been reported in
several cell types that underwent a heat-shock response (39,40);
however, this is the first report of this kind of reorganization in
MC. These changes could constitute part of the defense mech-
anisms triggered by 15d-PGJ2 in MC. We also observed a fading
of the microtubule network in MC at early times of treatment
with 15d-PGJ2. In contrast, the distribution of the actin cytoskel-
eton did not show significant changes within the time frame
explored.
The effects of 15d-PGJ2 on MC cytoskeletal distribution could
be mediated by the direct modification of cytoskeletal proteins.
All proteins that were identified in this study possess cysteine
residues that are susceptible to oxidative modifications, and
some of them have been reported recently to undergo thiolation
under oxidative stress (35,36,41). The modification of exposed
sulfhydryl groups in cytoskeletal proteins may play a regula-
tory role, thus transducing oxidative stress signals into cy-
toskeletal changes. Tubulin is a cysteine-rich redox-sensitive
Figure 7. Effects of 15d-PGJ2 on cytoskeletal organization in MC. (A) MC were treated for 2 h in the absence or presence of 5 M
15d-PGJ2, as indicated, and stained with antibodies against vimentin (green), tubulin (green), or RhoGDI (red) or with phalloidin
to visualize filamentous actin (orange). Nuclei were stained with DAPI (blue). (B) Levels of total vimentin and tubulin were
assessed by Western blot. (C) MC were treated for 2 h with 5 M 9,10-dihydro-15d-PGJ2 or biotinylated 15d-PGJ2. After fixation,
cells were stained with antibodies against vimentin or tubulin, as indicated, and DAPI. Bar  47.62 m. Confocal fluorescence
microscopy images shown are maximum projections of series acquired at 0.5-m intervals and are representative of three
experiments with similar results.
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protein that plays a crucial function in cell division. Modifica-
tion of tubulin redox state or alkylation of functional sulfhydryl
groups may lead to impairment of microtubule polymerization
and inhibition of cellular proliferation (42). This feature has
been exploited for the development of anticancer agents (43,44).
Thus, it could be hypothesized that modification of tubulin by
cyPG may be involved in the antiproliferative effects of these
compounds. Vimentin contains a single cysteine residue that is
highly conserved among vertebrates. Vimentin glutathionyla-
tion has been detected in oxidatively stressed T lymphocytes
(41). However, the consequences of this modification for cy-
toskeletal organization have not been explored. Using a C328S
vimentin mutant, we observed that the presence of this cysteine
residue is important for the full effect of 15d-PGJ2 on vimentin
reorganization. Our results suggest that modification of this
residue could have important consequences for the organiza-
tion of intermediate filaments.
The possibility should also be considered that 15d-PGJ2 could
alter cytoskeletal organization by indirect mechanisms, includ-
ing modification of proteins that are involved in the regulation
of redox status, chaperones, G-proteins, or microtubule-inter-
acting proteins. It has been reported that 15d-PGJ2 can bind to
the CRTH2 chemoattractant G-protein–coupled receptor at
nanomolar concentrations (45). However, involvement of this
pathway in the effects herein reported is unlikely because nano-
molar concentrations of 15d-PGJ2 or of the CRTH2 agonist
indomethacin did not elicit Hsp70 induction, iNOS inhibition,
or cytoskeletal remodeling (unpublished observations). At mi-
cromolar concentrations, 15d-PGJ2 can also activate PPAR.
Nevertheless, the compound 9,10-dihydro-15d-PGJ2, a potent
PPAR- agonist that lacks the cyclopentenone moiety, failed to
induce cytoskeletal reorganization in MC. This observation also
supports the hypothesis that covalent modification of cellular
thiols plays an important role in the effects of 15d-PGJ2 on
intermediate filament and microtubule networks. The precise
concentrations of 15d-PGJ2 in biologic systems are still a matter
of debate, as it has been discussed previously (14,25). However,
this issue does not preclude the interest of the protective effects
of cyPG and of their use as model compounds to explore the
biologic effects and targets of endogenous cyclopentenone ei-
cosanoids with similar chemical reactivity that have been de-
tected in various biologic systems (46,47).
In summary, we have identified physiologically relevant tar-
gets for modification by cyPG. These findings may open new
avenues for the understanding of the pleiotropic effects of cyPG
and may help to define their potential use as therapeutic
agents.
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